HCPCS Level II code J2781 describes the intravitreal injection formulation of pegcetacoplan, billed per 1 mg unit; this code represents administration of an ophthalmic complement inhibitor delivered via intravitreal injection as the service type, typically provided in an ophthalmology clinic, ambulatory surgery center, or hospital outpatient department for retinal disease management.

For related coverage guidance, see recent payer policy updates: Epithelial Cell Cytology in Breast Cancer Risk Assessment, Antibody-Drug Conjugates, Chemotherapy Observation or Inpatient Hospitalization (for New Mexico Only).